Exposure to Systemic Antimicrobials During Pregnancy and Risk of Miscarriage: A Population-Based Registry Study
- PMID: 40151928
- DOI: 10.1111/1471-0528.18155
Exposure to Systemic Antimicrobials During Pregnancy and Risk of Miscarriage: A Population-Based Registry Study
Abstract
Objective: To estimate miscarriage risk following gestational antimicrobial exposure while addressing biases that have affected previous studies.
Design: Population-based cohort study.
Setting: Linkage of four nationwide registries: Medical Birth Registry of Norway (MBRN), Norwegian Prescribed Drug Registry (NorPD), Norwegian Patient Registry (NPR) and Norwegian Control and Payment of Health Reimbursements Database (KUHR).
Population or sample: A total of 704 082 pregnancies (2009-2018), with 91 836 (13.0%) exposed to systemic antimicrobials in early pregnancy.
Methods: Time-stratified Cox regression models with overlap weights were used, considering time-varying exposures and a 14-day lag to prevent reverse causation. Elective terminations were right-censored to address competing risks, with adjustment for common infections and probabilistic bias analysis for confounding by indication.
Main outcome measures: Miscarriage and gestational age at miscarriage, captured from NPR, KUHR and MBRN, using the UiO pregnancy algorithm.
Results: Nitrofurantoin, pivmecillinam and amoxicillin were not associated with increased miscarriage risk. Metronidazole (HR = 2.00; 95% CI: 1.82-2.21), ciprofloxacin (HR = 1.89; 95% CI: 1.62-2.20), cephalexin (HR = 1.87; 95% CI: 1.57-2.22), fluconazole (HR = 1.61; 95% CI: 1.45-1.78), trimethoprim-sulfas (HR = 1.49; 95% CI: 1.36-1.63) and others showed associations with miscarriage. Probabilistic bias analysis indicated that associations for common antimicrobials may be driven by the underlying infections.
Conclusions: Nitrofurantoin, pivmecillinam and amoxicillin did not increase miscarriage risk, but other less commonly used antimicrobials may carry higher risks. By addressing key biases, this study provided a more reliable assessment of miscarriage risks associated with antimicrobial use in early pregnancy.
Keywords: antibiotics; antimycotics; competing risk; elective termination; miscarriage; time‐related bias.
© 2025 The Author(s). BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
References
-
- N. H. Thurin, R. Pajouheshnia, G. Roberto, et al., “From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding,” Clinical Pharmacology & Therapeutics 111 (2022): 321–331, https://doi.org/10.1002/cpt.2476.
-
- “Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products‐Content and Format Guidance for Industry, 2024”, https://www.fda.gov/media/90160/download.
-
- M. C. Magnus, A. J. Wilcox, N.‐H. Morken, C. R. Weinberg, and S. E. Håberg, “Role of Maternal Age and Pregnancy History in Risk of Miscarriage: Prospective Register Based Study,” BMJ 364 (2019): l869, https://doi.org/10.1136/bmj.l869.
-
- J. S. Cohain, R. E. Buxbaum, and D. Mankuta, “Spontaneous First Trimester Miscarriage Rates per Woman Among Parous Women With 1 or More Pregnancies of 24 Weeks or More,” BMC Pregnancy and Childbirth 17, no. 1 (2017): 437.
-
- G. G. Briggs, R. K. Freeman, and S. J. Yaffe, Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk (Lippincott Williams & Wilkins, 2011).
Grants and funding
LinkOut - more resources
Full Text Sources
